CureVac N.V.
NASDAQ:CVAC
3.29 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 52.656 | 67.42 | 102.99 | 48.9 | 17.416 | 12.871 |
| Cost of Revenue
| 143.736 | 183.993 | 238.195 | 14.173 | 27.983 | 17.744 |
| Gross Profit
| -91.08 | -116.573 | -135.205 | 34.727 | -10.567 | -4.873 |
| Gross Profit Ratio
| -1.73 | -1.729 | -1.313 | 0.71 | -0.607 | -0.379 |
| Reseach & Development Expenses
| 104.988 | 62.55 | 815.907 | 113.808 | 43.242 | 41.722 |
| General & Administrative Expenses
| 76.009 | 88.994 | 87.201 | 45.029 | 42.183 | 20.415 |
| Selling & Marketing Expenses
| 0.424 | 0.417 | 1.743 | 0.733 | 1.755 | 1.085 |
| SG&A
| 80.154 | 89.411 | 88.944 | 45.762 | 43.938 | 21.5 |
| Other Expenses
| -0 | -17.682 | -627.793 | -0.87 | 1.75 | 4.729 |
| Operating Expenses
| 185.142 | 134.279 | 277.058 | 158.7 | 88.93 | 67.951 |
| Operating Income
| -276.222 | -249.457 | -412.263 | -124.002 | -99.498 | -72.824 |
| Operating Income Ratio
| -5.246 | -3.7 | -4.003 | -2.536 | -5.713 | -5.658 |
| Total Other Income Expenses Net
| 21.581 | 0.302 | -0.235 | -5.798 | -0.627 | 1.693 |
| Income Before Tax
| -254.64 | -249.155 | -412.498 | -129.8 | -100.125 | -71.131 |
| Income Before Tax Ratio
| -4.836 | -3.696 | -4.005 | -2.654 | -5.749 | -5.526 |
| Income Tax Expense
| 0.194 | -0.126 | -0.782 | -0.726 | -0.252 | 0.11 |
| Net Income
| -254.834 | -249.029 | -411.716 | -129.074 | -99.873 | -71.241 |
| Net Income Ratio
| -4.84 | -3.694 | -3.998 | -2.64 | -5.735 | -5.535 |
| EPS
| -1.15 | -1.32 | -2.21 | -0.98 | -0.53 | -0.4 |
| EPS Diluted
| -1.15 | -1.32 | -2.21 | -0.98 | -0.53 | -0.4 |
| EBITDA
| -249.552 | -223.102 | -386.486 | -109.8 | -91.501 | -67.075 |
| EBITDA Ratio
| -4.739 | -3.309 | -3.753 | -2.245 | -5.254 | -5.211 |